ZNF213
gene geneOn this page
Also known as CR53ZKSCAN21ZSCAN53
Summary
ZNF213 (zinc finger protein 213, HGNC:13005) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 213 (O14771). May be involved in transcriptional regulation.
C2H2 zinc finger proteins, such as ZNF213, have bipartite structures in which one domain binds DNA or RNA and the other modulates target gene expression.
Source: NCBI Gene 7760 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_004220
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13005 |
| Approved symbol | ZNF213 |
| Name | zinc finger protein 213 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CR53, ZKSCAN21, ZSCAN53 |
| Ensembl gene | ENSG00000085644 |
| Ensembl biotype | protein_coding |
| OMIM | 608387 |
| Entrez | 7760 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000396878, ENST00000572647, ENST00000573771, ENST00000574575, ENST00000574902, ENST00000574928, ENST00000576416, ENST00000576863
RefSeq mRNA: 2 — MANE Select: NM_004220
NM_001134655, NM_004220
CCDS: CCDS10495
Canonical transcript exons
ENST00000396878 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001778499 | 3135029 | 3135387 |
| ENSE00002203200 | 3137166 | 3137679 |
| ENSE00002673948 | 3140689 | 3142804 |
| ENSE00003572651 | 3138745 | 3138818 |
| ENSE00003646385 | 3138975 | 3139098 |
| ENSE00003750197 | 3138418 | 3138541 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 96.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.0502 / max 41.6971, expressed in 1663 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152400 | 2.0723 | 1306 |
| 152397 | 1.1340 | 643 |
| 152398 | 0.7539 | 477 |
| 152399 | 0.0900 | 23 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.46 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.07 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 93.20 | silver quality |
| parotid gland | UBERON:0001831 | 91.48 | gold quality |
| myocardium | UBERON:0002349 | 90.59 | silver quality |
| kidney epithelium | UBERON:0004819 | 90.02 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 89.95 | gold quality |
| right testis | UBERON:0004534 | 87.69 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.58 | gold quality |
| left testis | UBERON:0004533 | 87.45 | gold quality |
| endothelial cell | CL:0000115 | 87.31 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 86.75 | silver quality |
| upper arm skin | UBERON:0004263 | 86.51 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 86.26 | silver quality |
| ileal mucosa | UBERON:0000331 | 86.25 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 86.06 | gold quality |
| testis | UBERON:0000473 | 86.00 | gold quality |
| quadriceps femoris | UBERON:0001377 | 85.68 | silver quality |
| vastus lateralis | UBERON:0001379 | 85.07 | silver quality |
| gingival epithelium | UBERON:0001949 | 85.04 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.93 | gold quality |
| lower lobe of lung | UBERON:0008949 | 84.85 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 84.49 | gold quality |
| gingiva | UBERON:0001828 | 84.40 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 84.01 | gold quality |
| entorhinal cortex | UBERON:0002728 | 83.92 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 83.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.36 | gold quality |
| cortical plate | UBERON:0005343 | 83.23 | gold quality |
| superficial temporal artery | UBERON:0001614 | 83.17 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-4850 | no | 4.44 |
| E-ANND-3 | no | 2.92 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2121.1 | ZNF213 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:27852650
miRNA regulators (miRDB)
67 targeting ZNF213, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-371A-3P | 99.99 | 66.77 | 91 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-520F-3P | 99.82 | 71.32 | 1216 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-6794-5P | 99.76 | 66.38 | 1048 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-1296-3P | 99.72 | 64.04 | 636 |
| HSA-MIR-4716-3P | 99.69 | 66.73 | 1022 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-6848-3P | 99.64 | 66.49 | 885 |
| HSA-MIR-9851-3P | 99.63 | 69.68 | 1110 |
| HSA-MIR-6132 | 99.60 | 65.83 | 1554 |
| HSA-MIR-6836-5P | 99.60 | 65.62 | 1538 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. (PMID:33939216)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp213 | ENSMUSG00000071256 |
| rattus_norvegicus | Zfp213 | ENSRNOG00000021872 |
Paralogs (30): ZNF263 (ENSG00000006194), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger protein 213 — O14771 (reviewed: O14771)
Alternative names: Putative transcription factor CR53, Zinc finger protein with KRAB and SCAN domains 21
All UniProt accessions (6): O14771, A0A0S2Z4L6, I3L1Z4, I3L216, I3L2V8, I3L473
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Widely expressed with highest levels in testis.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O14771-1 | 1 | yes |
| O14771-2 | 2 |
RefSeq proteins (2): NP_001128127, NP_004211* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
| IPR050717 | C2H2-ZF_Transcription_Reg | Family |
Pfam: PF00096, PF01352, PF02023, PF13465
UniProt features (12 total): zinc finger region 5, domain 2, splice variant 2, chain 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14771-F1 | 66.13 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 77 (showing top):
GTGCCTT_MIR506, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, NIKOLSKY_BREAST_CANCER_16P13_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, KATSANOU_ELAVL1_TARGETS_DN, AKT_UP.V1_DN, MTOR_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, CEBPZ_TARGET_GENES, DLX4_TARGET_GENES, E2F2_TARGET_GENES, FEV_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
492 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF213 | OR1F1 | O43749 | 447 |
| ZNF213 | PSPC1 | Q8WXF1 | 441 |
| ZNF213 | NONO | P30807 | 432 |
| ZNF213 | THUMPD3 | Q9BV44 | 431 |
| ZNF213 | TIGD7 | Q6NT04 | 419 |
| ZNF213 | SFPQ | P23246 | 396 |
| ZNF213 | GABPA | Q06546 | 395 |
| ZNF213 | PAGR1 | Q9BTK6 | 379 |
| ZNF213 | PKIB | Q9C010 | 352 |
| ZNF213 | TRNAU1AP | Q9NX07 | 337 |
| ZNF213 | RNF187 | Q5TA31 | 325 |
| ZNF213 | RNF181 | Q9P0P0 | 321 |
| ZNF213 | GDE1 | Q9NZC3 | 319 |
| ZNF213 | PDZK1 | Q5T2W1 | 309 |
| ZNF213 | RNF31 | Q96EP0 | 301 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF213 | ZSCAN21 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF213 | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF397 | ZNF213 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF213 | LNX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF213 | FBXO17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF213 | EEF2KMT | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF213 | LMO4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF213 | PPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN32 | ZNF197 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF397 | ZNF197 | psi-mi:“MI:0914”(association) | 0.530 |
| ZKSCAN4 | ZNF213 | psi-mi:“MI:0914”(association) | 0.530 |
| PGBD1 | ZNF213 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF213 | ZNF24 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF213 | CFTR | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZSCAN20 | ZNF197 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF232 | ZNF197 | psi-mi:“MI:0914”(association) | 0.350 |
| ZSCAN1 | ZNF213 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF213 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| ZKSCAN8 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| MZF1 | ZNF213 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF213 | BMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| TGIF2 | ZNF213 | psi-mi:“MI:0914”(association) | 0.350 |
| LNX1 | ZNF213 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (42): ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Two-hybrid), EEF2KMT (Two-hybrid), PPL (Two-hybrid), LMO4 (Two-hybrid)
ESM2 similar proteins: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A6NDS4, A6NER0, A6QPT6, B9A6J9, M3WHG5, O14771, O15482, O15553, O19110, O76081, P0C7X1, P0C7X3, P0C7X4, P35125, P48778, P48967, P79209, Q13670, Q15697, Q2TBC4, Q3T191, Q3UZD7, Q4R2Z8, Q5DRQ5, Q5SSQ6, Q5XFX8, Q69ZB3, Q6DHY5, Q6IPX1, Q6ZMN8, Q8BLR5, Q8BWA8, Q8IYF1, Q8IZP1, Q8JZW5, Q8N7G0
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 10 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1300 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3135059:G:GT | donor_gain | 1.0000 |
| 16:3137676:ACAGG:A | donor_loss | 1.0000 |
| 16:3137678:AGGT:A | donor_loss | 1.0000 |
| 16:3137680:G:GC | donor_loss | 1.0000 |
| 16:3137681:T:G | donor_loss | 1.0000 |
| 16:3138412:GCACA:G | acceptor_loss | 1.0000 |
| 16:3138413:CACA:C | acceptor_loss | 1.0000 |
| 16:3138414:ACAG:A | acceptor_gain | 1.0000 |
| 16:3138415:CA:C | acceptor_loss | 1.0000 |
| 16:3138416:A:AG | acceptor_gain | 1.0000 |
| 16:3138416:AG:A | acceptor_gain | 1.0000 |
| 16:3138417:G:GC | acceptor_loss | 1.0000 |
| 16:3138417:G:GG | acceptor_gain | 1.0000 |
| 16:3138417:GG:G | acceptor_gain | 1.0000 |
| 16:3138417:GGAT:G | acceptor_gain | 1.0000 |
| 16:3138537:TAGCG:T | donor_gain | 1.0000 |
| 16:3138538:AGCG:A | donor_gain | 1.0000 |
| 16:3138539:GCG:G | donor_gain | 1.0000 |
| 16:3138539:GCGG:G | donor_gain | 1.0000 |
| 16:3138540:CG:C | donor_gain | 1.0000 |
| 16:3138540:CGGTG:C | donor_loss | 1.0000 |
| 16:3138541:GG:G | donor_gain | 1.0000 |
| 16:3138541:GGT:G | donor_loss | 1.0000 |
| 16:3138542:G:GA | donor_loss | 1.0000 |
| 16:3138542:G:GG | donor_gain | 1.0000 |
| 16:3138546:G:GG | donor_gain | 1.0000 |
| 16:3138743:A:AG | acceptor_gain | 1.0000 |
| 16:3138744:G:GG | acceptor_gain | 1.0000 |
| 16:3138744:GCCC:G | acceptor_gain | 1.0000 |
| 16:3138744:GCCCA:G | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000267260 (16:3139962 C>T), RS1000445393 (16:3133235 G>C,T), RS1000476568 (16:3133054 G>A), RS1000486670 (16:3134851 C>T), RS1000570780 (16:3134575 T>C), RS1000773259 (16:3143024 C>T), RS1001381950 (16:3140600 G>A,T), RS1001605999 (16:3142989 C>T), RS1001663519 (16:3135138 G>C), RS1001733177 (16:3134889 A>G), RS1001945149 (16:3136475 T>C), RS1002958448 (16:3136310 T>C), RS1003151959 (16:3141792 C>G), RS1003281531 (16:3142083 G>GC), RS1003384265 (16:3142725 G>A,T)
Disease associations
OMIM: gene MIM:608387 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002119_1 | Metabolite levels (X-11787) | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005276 | hydroxy-leucine measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | affects binding, decreases reaction | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW19 | HEK293 eGFP-ZNF213 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.